Domperidone in Treating Patients With Gastrointestinal Disorders
Status:
Recruiting
Trial end date:
2021-10-31
Target enrollment:
Participant gender:
Summary
This phase III trial studies how well domperidone works in treating patients with
gastrointestinal disorders. Domperidone may help control chronic gastrointestinal disorders
and their symptoms, such as pain, bloating, and nausea and vomiting, by stimulating
contraction of the stomach to increase its ability to empty itself of food.